Health Catalyst (NASDAQ: HCAT) is one of 59 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it weigh in compared to its peers? We will compare Health Catalyst to similar companies based on the strength of its dividends, valuation, analyst recommendations, institutional ownership, risk, earnings and profitability.
This is a breakdown of recent ratings and recommmendations for Health Catalyst and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Health Catalyst Competitors||960||3235||6438||319||2.56|
Health Catalyst presently has a consensus price target of $47.38, indicating a potential upside of 84.34%. As a group, “Computer programming, data processing, & other computer related” companies have a potential upside of 110.47%. Given Health Catalyst’s peers higher probable upside, analysts plainly believe Health Catalyst has less favorable growth aspects than its peers.
Insider and Institutional Ownership
62.9% of Health Catalyst shares are owned by institutional investors. Comparatively, 52.8% of shares of all “Computer programming, data processing, & other computer related” companies are owned by institutional investors. 14.7% of shares of all “Computer programming, data processing, & other computer related” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares Health Catalyst and its peers revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Health Catalyst||$154.94 million||-$60.10 million||-18.10|
|Health Catalyst Competitors||$8.32 billion||$1.62 billion||44.83|
Health Catalyst’s peers have higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This table compares Health Catalyst and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Health Catalyst Competitors||-4.05%||-54.08%||-3.57%|
Health Catalyst beats its peers on 7 of the 12 factors compared.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.